TY - JOUR
T1 - Patterns and biologic features of p53 mutation types in Korean breast cancer patients
AU - Kim, Hyung Won
AU - Lee, Hak Min
AU - Hwang, Seung Hyun
AU - Ahn, Sung Gwe
AU - Lee, Kyung A.
AU - Jeong, Joon
PY - 2014/3
Y1 - 2014/3
N2 - Purpose: The p53 gene is one of the most frequently mutated genes in breast cancer. We investigated the patterns and biologic features of p53 gene mutation and evaluated their clinical signifi-cance in Korean breast cancer patients. Methods: Patients who underwent p53 gene sequencing were included. Mutational analysis of exon 5 to exon 9 of the p53 gene was carried out using polymerase chain reaction-denaturing high performance liquid chromatography and direct sequencing. Results: A total of 497 patients were eligible for the present study and p53 gene mutations were detected in 71 cases (14.3%). Mutation of p53 was significantly associated with histologic grading (p< 0.001), estrogen receptor and progesterone receptor status (p< 0.001), HER2 status (p< 0.001), Ki-67 (p=0.028), and tumor size (p=0.004). The most frequent location of p53 mutations was exon 7 and missense mutation was the most common type of mutation. Compared with patients without mutation, there was a statistically significant difference in relapse-free survival of patients with p53 gene mutation and missense mutation (p= 0.020, p= 0.006, respectively). Only p53 missense mutation was an independent prognostic factor for relapse-free survival in multivariate analysis, with an adjusted hazard ratio of 2.29 (95% confidence interval, 1.08-4.89, p=0.031). Conclusion: Mutation of the p53 gene was associated with more aggressive clinicopathologic characteristics and p53 missense mutation was an independent negative prognostic factor in Korean breast cancer patients.
AB - Purpose: The p53 gene is one of the most frequently mutated genes in breast cancer. We investigated the patterns and biologic features of p53 gene mutation and evaluated their clinical signifi-cance in Korean breast cancer patients. Methods: Patients who underwent p53 gene sequencing were included. Mutational analysis of exon 5 to exon 9 of the p53 gene was carried out using polymerase chain reaction-denaturing high performance liquid chromatography and direct sequencing. Results: A total of 497 patients were eligible for the present study and p53 gene mutations were detected in 71 cases (14.3%). Mutation of p53 was significantly associated with histologic grading (p< 0.001), estrogen receptor and progesterone receptor status (p< 0.001), HER2 status (p< 0.001), Ki-67 (p=0.028), and tumor size (p=0.004). The most frequent location of p53 mutations was exon 7 and missense mutation was the most common type of mutation. Compared with patients without mutation, there was a statistically significant difference in relapse-free survival of patients with p53 gene mutation and missense mutation (p= 0.020, p= 0.006, respectively). Only p53 missense mutation was an independent prognostic factor for relapse-free survival in multivariate analysis, with an adjusted hazard ratio of 2.29 (95% confidence interval, 1.08-4.89, p=0.031). Conclusion: Mutation of the p53 gene was associated with more aggressive clinicopathologic characteristics and p53 missense mutation was an independent negative prognostic factor in Korean breast cancer patients.
UR - http://www.scopus.com/inward/record.url?scp=84898457350&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84898457350&partnerID=8YFLogxK
U2 - 10.4048/jbc.2014.17.1.1
DO - 10.4048/jbc.2014.17.1.1
M3 - Article
AN - SCOPUS:84898457350
SN - 1738-6756
VL - 17
SP - 1
EP - 7
JO - Journal of Breast Cancer
JF - Journal of Breast Cancer
IS - 1
ER -